Alpha DNA Investment Management’s Toll Brothers TOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,013
Closed -$631K 165
2024
Q4
$631K Buy
5,013
+278
+6% +$41.3K 0.24% 88
2024
Q3
$732K Buy
4,735
+645
+16% +$87.5K 0.27% 87
2024
Q2
$471K Sell
4,090
-3,074
-43% -$372K 0.18% 125
2024
Q1
$927K Buy
7,164
+3,056
+74% +$333K 0.34% 59
2023
Q4
$422K Buy
4,108
+1,338
+48% +$111K 0.16% 150
2023
Q3
$205K Sell
2,770
-10,243
-79% -$809K 0.08% 164
2023
Q2
$1.03M Sell
13,013
-4,631
-26% -$311K 0.34% 69
2023
Q1
$1.06M Buy
+17,644
New +$1.02M 0.31% 98

Other funds holding TOL

Alpha DNA Investment Management's TOL Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Toll Brothers (TOL) in Q1 2025, closing a stake of 5,013 shares — an estimated $631K sold.

Alpha DNA Investment Management first reported a position in TOL in Q1 2023 and held it in 8 quarters. The position peaked at $1.06M in Q1 2023. 661 funds tracked by Wall St. Rank hold TOL as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Toll Brothers position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,013 Toll Brothers shares in Q1 2025, an estimated $631K.
  • Alpha DNA Investment Management first reported a position in Toll Brothers in Q1 2023 and held it in 8 quarters.
  • Alpha DNA Investment Management's Toll Brothers position peaked at $1.06M in Q1 2023.
  • 661 funds tracked by Wall St. Rank held Toll Brothers as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.